TARPLIN, DOWNS & YOUNG, LLC

Lobbying for JAZZ PHARMACEUTICALS INC. · A specialty biopharmaceutical company

Filing 4th Quarter - Report

4th Quarter (Oct 1 - Dec 31) 2025 · California · House · Senate · $80,000.00 income · posted Jan 20, 2026

Lobbying activity 1

Health Issues

Regulation of botanical products Drug safety, prescription drug abuse, value of prescription drugs; Issues related to drug pricing Expiring healthcare extenders Issues related to BIOSECURE

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.